Valentina Calò

Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study

Viviana Bazan, Valentina Agnese, S Corsale et al. · Annals of Oncology · 2005 · 77 citations · Full text

Medicine, Oncology, Pathology +17

Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge

Marco Bono, Daniele Fanale, Lorena Incorvaia et al. · ESMO Open · 2021 · 67 citations · Full text

Life Sciences, Genetics, Oncology +17

Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

Francesco Passiglia, Antonio Galvano, Marta Castiglia et al. · Therapeutic Advances in Medical Oncology · 2019 · 65 citations · Full text

Medicine, Molecular Medicine, Oncology +17

<i>BRCA1/2</i> pathogenic variants in triple-negative <i>versus</i> luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients

Lorena Incorvaia, Daniele Fanale, Marco Bono et al. · Therapeutic Advances in Medical Oncology · 2020 · 64 citations · Full text

Medicine, Genetics, Oncology +17

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2

Daniele Fanale, Lorena Incorvaia, Clarissa Filorizzo et al. · Cancers · 2020 · 57 citations · Full text

Life Sciences, Genetics, Oncology +17